Patient classification system for I.V. therapy.

D R Baldwin

PubMed · 2795333

Patient classification system for I.V. therapy.

Abstract

Patient classification systems may be used to justify I.V. work load. The merits of such a system include accurate prediction of staffing requirements based on patient care needs, validation of the I.V. nursing team's productivity and cost-effectiveness, prioritization of the I.V. nursing work load, and evaluation of the quality of I.V. nursing care.

Explore related subjects

Efficiency Fluid Therapy Humans Patients Personnel Management Personnel Staffing and Scheduling Quality of Health Care Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

D R Baldwin. Patient classification system for I.V. therapy.. https://pubmed.ncbi.nlm.nih.gov/2795333/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Is your practice fulfilling?

Explore the source record for details and available documents.

Efficiency↗

PubMed2006

Severity of illness and the welfare effects of moral hazard.

The extent to which the moral hazard caused by health insurance represents economic inefficiency has been the subject of much debate. This paper incorporates health status in a model of moral hazard, and finds that seriously ill patients are likely to exhibit greater moral hazard than healthier patients but the proportion of moral hazard that is inefficient declines with the severity of illness. Because of these competing tendencies, the cost of resource misallocation is parabolic in the severity of illness. The effect of the consumer's initial wealth endowment is also considered.

Efficiency↗

PubMed2006

Improved production of ethanol by deleting FPS1 and over-expressing GLT1 in Saccharomyces cerevisiae.

To improve ethanol production in Saccharomyces cerevisiae, two yeast strains were constructed. In the mutant KAM-3, the FPS1 gene, which encodes a channel protein responsible for glycerol export, was deleted. The mutant KAM-11 had the GLT1 gene (encoding glutamate synthase) placed under the PGK1 promoter while having the FPS1 deletion. Growth rate and biomass concentration remained virtually unchanged with the mutant KAM-11, compared to that of the parent. Over-expression of GLT1 by the PGK1 promoter along with FPS1 deletion resulted in a 14% higher ethanol production and a 30% lower glycerol formation compared to the parental strain under anaerobic fermentation conditions. Furthermore, acetate and pyruvic acid formation was also reduced in order for cells to maintain redox balance.

Efficiency↗